Field veterinarians, laboratory diagnosticians and disease control officials will be confronted by new methods of diagnosis. Professionals dealing with infectious diseases will have to become familiar with these techniques. The primary purpose of this review is to point out new research focusing on diagnosis by restriction enzyme analysis (REA) and nucleic acid probes. The polymerase chain reaction (PCR) and production of antigens for diagnostic tests will also be discussed. Monoclonal antibodies and ELISA are widely employed in infectious disease diagnosis. Consequently, their use is more appropriately discussed under specific disease agents in other publications. However, currently a major use of monoclonal antibodies is in competitive inhibition diagnostic tests. These tests will be briefly discussed.
The use of restriction enzyme analysis, nucleic acid probes is relegated to specialized laboratories principally involved in basic research or developing diagnostic tests. Within the next few years, the use of these new techniques for routine diagnosis may no longer be cumbersome and time consuming. The polymerase chain reaction for the in vitro amplification of DNA is already being used in a variety of diagnostic applications and has greatly improved the sensitivity of some diagnostic tests.
DIAGNOSIS BY RESTRICTION ENZYME ANALYSIS (REA)
The commonly employed serological tests to identify viruses are usually not sufficiently sensitive to distinguish closely-related isolates of a virus serotype or a virus mutant. Restriction enzyme analysis (nucleic acid fingerprinting) can detect differences in the genomes of the same virus serotypes (18, 40) . If it is desired to map the genome of a DNA virus, the DNA is extracted and clipped into fragments at specific nucleotide sequences. The resultant DNA fragments are then separated in agarose gel by electrophoresis and visualized with ethidium bromide. The fragments are then radiolabeled with complementary DNA (cDNA) tags with phosphorus 32 to determine the difference or similarities in the genomes.
An example for the possible use of REA in epidemiological studies is given in Fig. 1 . In this instance it might be employed to determine the differences/similarities in the genomes of three virus isolates. In this way the involvement of a particular isolate and the tracing of an isolate epidemiologically related within a country or between countries should be possible. Tables I and II document the use of REA [the material for these tables was derived from the MEDLINE Database System which is part of MEDLARS (Medical Literature Analysis and Retrieval System), a service of the National Library of Medicine of the United States].
TABLE I

Diagnosis of viral diseases by restriction endonuclease analysis (REA)
Disease
Significant findings Reference
Aujeszky's disease Except for the use of REA in epidemiological studies, the potential diagnostic value of REA is not clear. A question confronting veterinary diagnosticians in the future will be: what level of detected differences between viruses or bacteria is significant ? REA can detect single base pair substitutions in DNA based on the loss or acquisition of a restriction endonuclease site. However, if the loss or acquisition of restriction endonuclease site(s) is not represented by differences of the compared viruses or bacteria to cause disease, it may be concluded that the difference detected by REA is not significant. Where REA may prove extremely valuable is in the detection of a pathogenic strain of virus or bacteria when pathogenic and non-pathogenic strains cannot be differentiated serologically. This would of course depend on the difference in pathogenicity being represented by different REA patterns.
DIAGNOSIS BY DNA PROBES
The use of DNA hybridization procedures provides a powerful tool in the diagnosis of bacterial and virus diseases through the use of highly conserved DNA sequences. DNA probes exhibit remarkable specificity (6, 16, 65) .
Diagnosis of bacterial and other diseases by restriction endonuclease analysis (REA)
A simplistic illustration of the use of a probe is shown in Fig. 2 . To make a probe, DNA is heated or treated chemically until the two strands separate. Each strand will recognize and bind to a strand of DNA that has complementary nucleotide bases. To put it another way, a DNA probe will "search" the tissues of an animal or an insect for the complementary nucleotide (sequence) of a pathogen. To determine whether binding (hybridization) has occurred, the single strand of the probe DNA is usually labeled with radioactive 32 P.
Denatured DNA is freed from clinical specimens (blood, saliva, urine, exudates) and applied to nitrocellulose filters (dot-blot procedure). If the DNA sequence of the probe and the target DNA of the clinical specimen are complementary they will hybridize. Next, the filter is checked for the presence of the label of the probe. The specimen is positive for the pathogen if the label is detected. If the specimen is negative, the labeled probe will not bind to the sample and will be washed away in the procedure. Although the "hot" radioactive probes are very sensitive, they have some disadvantages. The 32 P isotope has a half-life of only a couple of weeks and is a radiation hazard.
To facilitate commercial use of DNA probes, radioactive tags will have to be replaced with sensitive, long shelf-life non-radiolabeled tags. Presently, most laboratories involved in making probes are utilizing the tenacious attraction of biotin and avidin from egg white. In this instance, the DNA probe is labeled with biotin and is detected by streptavidin, which is linked to horseradish peroxidase or alkaline phosphate which yield conspicuous color in the presence of their substrates and can be assayed. Also, the streptavidin can be conjugated with a fluorescent dye. Biotinlabeled probes have a long shelf-life, and the assay time can be reduced to a couple of hours, whereas the radiolabeling procedure usually requires an overnight radiograph. Some investigators using biotinylated probes have encountered sensitivity problems. A new technique which shows promise is the use of DNA probes labeled with the cholesterol digoxigenin and detected with an antibody-alkaline phosphatase conjugate and either a colorimetric or chemiluminescent substrate (5).
There are increasing numbers of research reports, but currently there are no DNA or RNA probes commercially available for use in veterinary diagnostic laboratories. Research papers in which DNA probes were employed are given in Tables III, IV and V.
POLYMERASE CHAIN REACTION
Polymerase chain reaction (PCR) procedure exploits natural DNA replication, mass producing in vitro a desired sequence of DNA. PCR can amplify two copies of a small region of 100 to 400 base pairs into millions of copies. The steps in the PCR process are outlined in three publications (28, 83, 84) .
Briefly, amplification of DNA by the PCR is accomplished via a succession of incubation steps at different temperatures. The target DNA is heat denatured; specific primers are then annealed at low temperature and extended with Taq DNA polymerase at an intermediate temperature utilizing the target DNA as a template (84) . These steps, referred to as cycles, are repeated 20 to 40 times, yielding amplification of target 
DNA Probe for Detectina Pathogens
Diagnosis of virus diseases by nucleic acid probes
Disease
Significant findings Reference
African swine fever A 32 P-DNA probe detected African swine fever virus in field samples.
15
Aujeszky's disease (Pseudorabies)
A practical in situ hybridization was developed for rapid diagnosis of Pseudorabies virus in pigs. The method utilizes routine formalin fixed and paraffin-embedded tissue sections.
8
The DNA hybridization procedure using 32 P probes may be useful for studying the latency of Aujeszky's disease (PRV). Argentine isolates of bovine herpesvirus-1 were detected by dot-blot nucleic acid hybridization using 32 P nick-translated plasmatic probes.
4
Bovine herpesvirus-1 (IBR)
Biotin-labeled DNA probes for IBR/IPV virus (BHV-1) were used to detect nucleic acid in infected cell cultures and clinical specimens by in situ hybridization.
26
Bovine herpesvirus-1 (IBR) BHV-1 DNA was detected in nasal swabs and exudate from experimentally infected cattle by blot hybridization.
25
Bovine herpesvirus-1
As little as 10 pg of BHV-1 DNA was detected by dot-blot hybridization with 32 P labeled DNA in bovine semen. 
Disease
Significant findings Reference
81
Porcine parvovirus (PPV)
The probe was evaluated by dot hybridization for PPV in infected cell cultures. The probe was specific for PPV-infected cells and 100 times more sensitive than the standard haemagglutination test.
49
Porcine parvovirus A DNA probe was capable of detecting one haemagglutinating unit in cell cultures and also detecting the virus in suspensions of internal organs from mummified fetuses of experimentally infected sows.
48
Rabies Rabies virus RNA was detected in paraffin tissues using in situ hybridization.
In situ hybridization has potential application as a diagnostic test for rabies and in studies for rabies pathogenesis.
43
Rinderpest and peste des petits ruminants cDNA probes can be used to distinguish rinderpest and peste des petits ruminants. 
Diagnosis of bacterial and other diseases by nucleic acid probes
Micro-organism Significant findings Reference
Corynebacterium kutschen
The method described is more rapid and more specific than conventional immunological and culture procedures used to detect C. kutscheri.
85
Escherichia coli
The method of hybridization permits the simultaneous examination of a large number of samples, but its application as a routine method would require the cloning of genes of all toxins.
57
Escherichia coli A non-radiological dot-blot hybridization test developed for enterotoxigenic E. coli was a more suitable approach in the field than the hybridization assay based on 32 P labeled DNA probes.
10
Escherichia coli
Biotinylated oligonucleotide probes were hybridized to detect the ST1a toxin gene.
46
Escherichia coli Blot hybridization was a reliable replacement for the ligated porcine gut loop assay to detect stable toxin-B producing E. coli.
55
Escherichia coli DNA probes were used to detect E. coli enterotoxins by the blot technique.
50
Escherichia coli
Commercial kits containing alkaline phosphatase-labeled oligonucleotide probes for E. coli heat-stable enterotoxins and heat-labile enterotoxin were compared with bioassays and radio-labeled recombinant probes to identify enterotoxigenic E. coli. There was very good agreement among the 3 methods.
63
Escherichia coli
Probes were prepared to determine prevalence of K99 adhesion factor and enterotoxins in E. coli isolates collected from cases of enteric and systemic disease. 
98
Listeria monocytogenes
A fragment of the beta-haemolysin gene from Listeria monocytogenes was used to screen different bacterial strains by DNA colony hybridization.
21
Mycoplasma A DNA probe was prepared for screening purposes.
47
Mycoplasma hyopneumoniae
A cloned fragment of M. hyopneumoniae DNA produced a probe capable of approximately 10 pg of the mycoplasma DNA.
93
Mycoplasma gallisepticum
The specificity and sensitivity of this probe were demonstrated by dot-blot and Southern hybridizations. 
86
Micro-organism Significant findings Reference
Mycoplasma gallisepticum
A biotinylated DNA probe detected M. gallisepticum within 24 hours. It reacted strongly with homologous and weakly with other mycoplasmas.
33
Mycoplasma gallisepticum
A DNA probe from the vaccine F strain (K810) and the reference S6-strain of M. gallisepticum were cloned in E. coli.
45
Mycoplasma gallisepticum and Mycoplasma synoviae
DNA probes specific for Mycoplasma gallisepticum and M. synoviae were hybridized with the DNA of a wide spectrum of strains within each homologous species but did not react with heterologous species or with DNA from any other avian mycoplasma or bacteria tested. The use of DNA probes for the early detection of M. gallisepticum infection can replace culture techniques and less effective serological methods.
42
Mycobacterium avium Complex
DNA probes hold promise for the future identification of Mycobacterium species in the clinical laboratory. Improvement in the shelflife and use of nonradioactive labels would greatly expand the usefulness of these probes.
80
Mycoplasma hyorhinis
A DNA probe for Mycoplasma hyorhinis demonstrated specific Southern hybridization and dot hybridization when tested against a group of different Mycoplasma spp.
94
Salmonella Salmonella species in meat products have been identified by DNA probes.
31
Salmonella newport A probe was developed to trace Salmonella newport in an epidemic.
90
Haemophilus ducreyi Three probes consistently detected H. ducreyi in pure and mixed cultures. The use of these probes will facilitate the laboratory diagnosis of the genital pathogen.
73
Campylobacter DNA probes that are specific for Campylobacter were developed.
78
Campylobacter See reference. 17
Salmonella DNA hybridization assays for the detection of salmonellae in foods were described.
TABLE V
Diagnosis of chlamydial and rickettsial diseases by nucleic acid probes
Micro-organism Significant findings Reference
Avian chlamydiae DNA-spot hybridization cell culture and direct immunofluorescence staining were compared for the detection of avian Chlamydia psittaci strains in cell culture and routine samples submitted for diagnosis. All three tests performed similarly.
99
Anaplasma marginale A nucleic acid probe was at least 4,000 times more sensitive than light microscopy. Hybridization of the probe with blood from anaplasmosis carrier cattle showed that parasitaemia was highly variable. Results suggest that at any given time individuals within a group of cattle may differ in their ability to transmit disease.
27
Anaplasma marginale A DNA probe was species specific and detected A. marginale DNA derived from bovine lymphocytes and Dermacentor ticks either as nymphs or adults.
37
Anaplasma marginale See reference 2 DNA sequences. The key to geometric amplification of target DNA sequences by the PCR is selection of paired primers which, when extended, will create additional reciprocal primer annealing sites for primer extension in subsequent cycles.
PCR is fast becoming a powerful tool in detecting infections in host tissues and vectors. Even when a small number of host cells are infected, PCR can target and amplify a gene sequence that has become integrated into the DNA of infected host cells.
The polymerase chain reaction may prove to be very useful in the diagnosis of chronic-persistent infections such as those caused by retroviruses (bovine leukemia virus, caprine arthritis-encephalitis virus, etc.) and tickborne hemoparasitic diseases (equine and bovine babesiosis, etc.). These diseases present serious problems in terms of diagnosis and prevention since infected animals often do not demonstrate clinical signs until there is advanced disease, and infected animals appear to be a constant potential source for transmission. While serological tests are usually accurate for identification of animals exposed to an organism, they do not provide information on the status of the particular organism within the individual animal. It was recently reported that the DNA of the human immunodeficiency virus (HIV) had been identified via PCR in patients which were serologically negative to HIV (74) . Should a similar situation be found in veterinary medicine; that is animals which are seronegative for an organism yet harbor its DNA, PCR could prove very useful in identifying such animals (Table VI) . This could be especially important in eradication programs.
TABLE VI
The use of the polymerase chain reaction (PCR)
Disease
Significant findings Reference
Feline herpesvirus (rhinotracheitis)
PCR increased the specificity of probes. 71
Leptospires Urine samples were investigated using PCR assay, culture isolation, dot-and quick-blot hybridization, and serological tests. This comparative study suggests that amplification by PCR may be a valuable method for the detection of leptospires in cattle urine.
30
PRODUCTION OF ANTIGENS BY RECOMBINANT DNA TECHNOLOGY
A problem which is encountered using current diagnostic tests is that the test antigens must be continuously produced from cell culture or harvested from an infected animal. These antigen preparations: 1) are expensive 2) often have a short shelf-life 3) need to be standardized with each new batch, and 4) potentially contain additional antigens which may be recognized by animals immunized with vaccines prepared from cell culture systems and may yield false positive tests. Production of antigens for diagnostic tests by molecularly cloning potentially overcomes these problems.
A general procedure for the preparation of an antigen by recombinant DNA technology is as follows. An antigen of potential diagnostic significance is identified by studying the antibody response of the host to the proteins of the organism in question. For example, immunodominance may be defined as those organism proteins against which there is the highest antibody titer. Following identification of proteins of potential diagnostic significance, specific reagents such as monoclonal antibodies or monospecific-polyvalent sera may be generated for use in screening recombinant libraries for the protein(s) of interest. Recombinant libraries may be produced from the genomic DNA of the organism or by cDNA synthesis using messenger RNA (mRNA) from the organism as a template. Preparation of genomic DNA for cloning is accomplished by random shearing followed by linker addition or partial digestion with a restriction endonuclease. In either case, the DNA is molecularly cloned into a prokaryotic or eukaryotic expression system, and the library screened for expression of the desired protein. An example for cloning a foreign gene into Escherichia coli for expression of a recombinant antigen is shown in Fig. 3 . The use and applications of recombinant antigens in diagnostic assays have recently been discussed (32) . 
MONOCLONAL ANTIBODIES (MAbs) FOR THE DIAGNOSIS OF DISEASE IN COMPETITIVE INHIBITION TESTS
Because of their specificity, MAbs have been widely used in the diagnosis of viral and bacterial diseases. Their preparation is given in Fig. 4 . It is not the purpose of this paper to review the numerous applications in which monoclonal antibodies have been successfully employed. There have been exhaustive reviews of monoclonal antibody technology as related to animal viruses and bacteria and the reader should consult the literature on specific diseases.
However, the use of monoclonal antibodies in competitive enzyme-linked immunosorbent assays (ELISA), also referred to as a blocking ELISA, has recently come to the forefront as a method to detect the presence of anti-organism antibody. Since introduced by Anderson (3), the use of monoclonal antibodies in a competitive ELISA is becoming widely used (1, 54) . A prominent advantage of the competitive ELISA is that the specificity is in the monoclonal and not the antigen preparation. This feature allows the use of crude antigen preparations. Briefly, the strategy is to incubate an antigen preparation from the organism in question with dilutions of test serum. A monoclonal antibody specific for the organism is then added and allowed to compete with the test serum for binding to the antigen preparation. Detection of monoclonal antibody binding may be accomplished by a number of different enzymes (alkaline phosphatase, etc.) which are conjugated to a second antibody. A positive serum inhibits the binding of the monoclonal antibody to the antigen preparation, and results in a titratable decrease in substrate cleavage by the enzyme conjugated to the second antibody. 
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